Investors suing Merck over ‘omissions and misstatements’ relating to its arthritis pain drug Vioxx will be allowed to continue with …

Generic versions of Merck’s hypertension treatments Cozaar and Hyzaar are to be launched in the US for the first time. …
Sanofi-Aventis and Merck have announced a joint venture, bringing together their animal health businesses Merial and Intervet/Schering-Plough. The company’s say …
Bridgette Heller has joined Merck & Co as executive vice president and president, consumer health care. She moves to Merck …
Merck has put its new pipeline on display for the first time since its October merger with Schering-Plough was completed. …
Merck’s HIV treatment vicriviroc has disappointed in phase III trials, and may be dropped by the company. The results failed …
Merck’s merger with Schering-Plough in October has helped boost the company’s full year sales by 13% to $27.4 billion.The gain …

Merck & Co has put a US public health and infectious diseases expert in charge of its $5 billion global …
The new corporate entity formed by the Merck & Co/Schering-Plough merger has at last opened its doors for business.The Schering-Plough …
Merck has turned in stable figures for the third quarter of the year, with global sales up 2% on the …
Merck KGaA has bought an Indian company specialising in research products in a deal it says will make it one …
Schering-Plough says it is planning to invest more than C$30 million ($28 million) to expand a pharmaceutical manufacturing facility in …
The oldest global pharma company Merck has received a Family Business Excellence Award, after impressing judges with the 12 generations …
Merck & Co has got rid of its interest in animal health products company Merial prior to the merger with …